Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

397

Participants

Timeline

Start Date

April 14, 2013

Primary Completion Date

May 12, 2014

Study Completion Date

January 9, 2019

Conditions
Psoriatic Arthritis
Interventions
DRUG

Secukinumab (AIN457)

Secukinumab (AIN457)

DRUG

Placebo

Placebo PFS for s.c. administration.

Trial Locations (76)

2217

Novartis Investigative Site, Kogarah

3000

Novartis Investigative Site, Leuven

3145

Novartis Investigative Site, Malvern East

3500

Novartis Investigative Site, Hasselt

3600

Novartis Investigative Site, Genk

4558

Novartis Investigative Site, Maroochydore

7000

Novartis Investigative Site, Hobart

10400

Novartis Investigative Site, Bangkok

12203

Novartis Investigative Site, Berlin

13210

Novartis Investigative Site, Syracuse

16635

Novartis Investigative Site, Duncansville

22081

Novartis Investigative Site, Hamburg

28210

Novartis Investigative Site, Charlotte

28801

Novartis Investigative Site, Asheville

29204

Novartis Investigative Site, Columbia

29460

Novartis Investigative Site, Charleston

29601

Novartis Investigative Site, Greenville

33180

Novartis Investigative Site, Aventura

33321

Novartis Investigative Site, Tamarac

33542

Novartis Investigative Site, Zephyrhills

33624

Novartis Investigative Site, Tampa

34239

Novartis Investigative Site, Sarasota

34684

Novartis Investigative Site, Palm Harbor

39261

Novartis Investigative Site, Zerbst

44649

Novartis Investigative Site, Herne

52064

Novartis Investigative Site, Aachen

53002

Novartis Investigative Site, Pardubice

68114

Novartis Investigative Site, Omaha

68516

Novartis Investigative Site, Lincoln

73102

Novartis Investigative Site, Oklahoma City

73103

Novartis Investigative Site, Oklahoma City

75150

Novartis Investigative Site, Mesquite

77573

Novartis Investigative Site, League City

82110

Novartis Investigative Site, Germering

85381

Novartis Investigative Site, Peoria

91054

Novartis Investigative Site, Erlangen

91056

Novartis Investigative Site, Erlangen

97080

Novartis Investigative Site, Würzburg

115522

Novartis Investigative Site, Moscow

150003

Novartis Investigative Site, Yaroslavl

185019

Novartis Investigative Site, Petrozavodsk

190068

Novartis Investigative Site, Saint Petersburg

197706

Novartis Investigative Site, Sestroretsk

344022

Novartis Investigative Site, Rostov-on-Don

420097

Novartis Investigative Site, Kazan'

454076

Novartis Investigative Site, Chelyabinsk

620028

Novartis Investigative Site, Yekaterinburg

07728

Novartis Investigative Site, Freehold

R3A 1M3

Novartis Investigative Site, Winnipeg

N2J 1C4

Novartis Investigative Site, Waterloo

H9R 3J1

Novartis Investigative Site, Pointe-Claire

G1W 4R4

Novartis Investigative Site, Québec

G1W 4Y5

Novartis Investigative Site, Sainte-Foy

G8Z 1Y2

Novartis Investigative Site, Trois-Rivières

792 01

Novartis Investigative Site, Bruntál

128 50

Novartis Investigative Site, Prague

686 01

Novartis Investigative Site, Uherské Hradiště

90-265

Novartis Investigative Site, Lodz

60 529

Novartis Investigative Site, Poznan

60-218

Novartis Investigative Site, Poznan

02 691

Novartis Investigative Site, Warsaw

04141

Novartis Investigative Site, Warsaw

50-368

Novartis Investigative Site, Wroclaw

00716

Novartis Investigative Site, Ponce

E11 1NR

Novartis Investigative Site, London

M6 8HD

Novartis Investigative Site, Salford

WS11 2XY

Novartis Investigative Site, Cannock

GU2 7XX

Novartis Investigative Site, Guildford

DY1 2HQ

Novartis Investigative Site, Dudley

LS7 4SA

Novartis Investigative Site, Leeds

FY3 7EN

Novartis Investigative Site, Blackpool

CB2 2QQ

Novartis Investigative Site, Cambridge

G51 4TF

Novartis Investigative Site, Glasgow

NW3 2QG

Novartis Investigative Site, London

SE1 9RT

Novartis Investigative Site, London

SO16 6YD

Novartis Investigative Site, Southampton

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY